Howard Marks’s Ingevity NGVT Stock Holding History

Howard Marks’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-261,810	Closed	-$8.91M	–	194
2016 Q2	$8.91M	Buy	+261,810	New	+$8.18M	0.16%	132

Other funds holding NGVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Howard Marks's NGVT Position: Q3 2016 in Review

Howard Marks sold out of Ingevity (NGVT) in Q3 2016, closing a stake of 261,810 shares — an estimated $8.91M sold.

Howard Marks first reported a position in NGVT in Q2 2016 and held it in 1 quarter. The position peaked at $8.91M in Q2 2016. 257 funds tracked by Wall St. Rank hold NGVT as of Q3 2016.

Howard Marks reported no remaining Ingevity position as of Q3 2016 after selling out during the quarter.
Howard Marks sold 261,810 Ingevity shares in Q3 2016, an estimated $8.91M.
Howard Marks first reported a position in Ingevity in Q2 2016 and held it in 1 quarter.
Howard Marks's Ingevity position peaked at $8.91M in Q2 2016.
257 funds tracked by Wall St. Rank held Ingevity as of Q3 2016.

Based on Oaktree Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.